Home/S&P 500/SGP

SGP — Schering-Plough

Unknown Industry · Unknown Sector

SpyGlass Pharma Inc. is a late-stage biopharmaceutical company dedicated to transforming the treatment paradigm for patients with chronic eye diseases through long-acting, sustained drug delivery. The company is developing two programs: the BIM-IOL System for delivering glaucoma medication during cataract surgery, and BIM-DRS, designed for glaucoma patients who have not undergone cataract surgery.

Key Facts

StatusActive
SectorUnknown Sector
IndustryUnknown Industry
Joined1957-03-04
Tenure52 yrs

S&P 500 Timeline

1957-03-04Joined S&P 500
2009-11-03Removed from S&P 500

Industry Peers

—

Sector Peers

—
Data source: Wikipedia · CC BY-SA 4.0 · Updated 2026-07-10